Attovia Therapeutics, Inc. (ATTO)
23.14
-0.52
(-2.20%)
USD |
NASDAQ |
Sep 09, 15:09
Attovia Therapeutics Debt to Equity Ratio : 0.0384 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0384 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0362 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 128.35M |
| Total Liabilities (Quarterly) | 15.58M |
| Shareholders Equity (Quarterly) | 112.77M |
| Current Ratio | 9.386 |